Oftalmologia

Estudo randomizado | Tratamento tópico do edema macular diabético com uso de suspensão oftálmica de dexametasona.

12 Ago, 2022 | 17:54h

Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study – Acta Ophthalmologica

Comentário: Topical Dexamethasone Ophthalmic Suspension OCS-01 Effective in DME Treatment – HCP Live

 

---

Revisão sistemática | Trabeculoplastia a laser para glaucoma de ângulo aberto e hipertensão ocular.

12 Ago, 2022 | 17:26h

Laser trabeculoplasty for open‐angle glaucoma and ocular hypertension – Cochrane Library

Resumo: Laser trabeculoplasty for open-angle glaucoma – Cochrane Library

Estudo relacionado: Randomized Trial: Selective Laser Trabeculoplasty vs. Eye Drops for First-line Treatment of Ocular Hypertension and Glaucoma

 

---

M-A | Tratamento do glaucoma neovascular.

10 Ago, 2022 | 14:20h

A systematic review and meta-analysis of randomised controlled trials in the management of neovascular glaucoma: absence of consensus and variability in practice – Graefe’s Archive for Clinical and Experimental Ophthalmology

 

---

Estudo de coorte retrospectiva | Avaliação retrospectiva de desfechos oftalmológicos e neurológicos em bebês nascidos antes de 24 semanas de idade gestacional.

9 Ago, 2022 | 17:06h

Retrospective evaluation of ophthalmological and neurological outcomes for infants born before 24 weeks gestational age in a Swedish cohort – BMJ Open

 

---

M-A | Agonistas receptores de GLP1 estão associados com risco aumentado de progressão de retinopatia em pacientes com diabetes tipo 2.

4 Ago, 2022 | 14:26h

Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis – Journal of Diabetes and its Complications (link para o resumo – $ para o texto completo)

Comentário: GLP1 RA use tied to increased risk of rapidly worsening retinopathy in type 2 diabetes – Medical Dialogues

 

---

Global Retinoblastoma Outcome Study | Análise baseada em grupos e prospectiva de 4.064 pacientes de 149 países.

18 Jul, 2022 | 12:33h

The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries – The Lancet Global Health

Comentário convidado: Retinoblastoma as a lens for correctable disparities worldwide – The Lancet Global Health

Comunicado de imprensa: Children in low-income countries 16 times more likely to die from most common eye cancer – London School of Hygiene & Tropical Medicine

 

---

Estudo de coorte retrospectiva | Achados prognósticos de ressonância magnética para desfechos visuais e de mortalidade na rinossinusite fúngica invasiva aguda.

7 Jul, 2022 | 11:51h

Magnetic Resonance Imaging Prognostic Findings for Visual and Mortality Outcomes in Acute Invasive Fungal Rhinosinusitis – Ophthalmology

---

Revisão sistemática | Rituximabe para oftalmopatia associada a tireoide.

21 Jun, 2022 | 12:52h

Rituximab for thyroid‐associated ophthalmopathy – Cochrane Library

Resumo: What are the benefits and risks of rituximab (a medicine that reduces inflammation) for the treatment of thyroid-associated ophthalmopathy (a disease affecting the tissues surrounding the eyes) – Cochrane Library

---

Este paciente com conjuntivite infecciosa aguda tem uma infecção bacteriana? Revisão sistemática de exame clínico racional.

19 Jun, 2022 | 17:14h

Does This Patient With Acute Infectious Conjunctivitis Have a Bacterial Infection? The Rational Clinical Examination Systematic Review – JAMA (gratuito por tempo limitado)

 

Comentário no Twitter

In this review, bacterial conjunctivitis was more common than viral conjunctivitis in children and viral conjunctivitis was more common than bacterial conjunctivitis in adults, although the prevalence estimates were based on limited evidence. https://t.co/wJ6YXxPRem

— JAMA (@JAMA_current) June 16, 2022

 

---

Revisão sistemática | Inibidor da Rho-quinase para glaucoma primário de ângulo aberto e hipertensão ocular.

19 Jun, 2022 | 14:57h

Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension – Cochrane Library

Resumo: Rho kinase inhibitors for primary open-angle glaucoma and ocular hypertension – Cochrane Library

---